Skip to main content

Nanomedicines: Overcoming Delivery Challenges with Lipid and Polymeric Platform Technologies

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Andrea Engel, Ph.D.

    Dr. Andrea Engel joined the Evonik’s Health Care business line in 2013 and is currently serving as Director Research & Development at Evonik’s Birmingham Laboratories focusing on parenteral drug delivery, biomaterials and medical device applications. Prior to her current role, she was Head of Drug Delivery, supporting internal R&D efforts and customers in the development and analysis of new oral and parenteral platform technologies for the pharma, food and cell culture industries. She received her degree in Pharmacy from the University of Frankfurt am Main, and her Ph.D. in Pharmaceutical Technology and Biopharmacy from the University of Muenster where she specialized in the development of drug delivery systems based on bioresorbable nanoparticles for cancer treatment. Andrea also holds an MBA degree from the Goethe Business School, Frankfurt. She has authored several research papers and patent application.

  • Natalia Zisman

    Natalia Zisman is a Manager of Process Development at Evonik Vancouver Laboratories, specializing in liposome and lipid nanoparticle drug delivery systems. She is responsible for facilitating technology transfer of customer projects from R&D to clinical manufacturing. Natalia has 20 years of experience in the liposome/lipid nanoparticle drug delivery field and has worked in a number of drug delivery companies prior to joining Evonik in 2014. She has been involved in all aspects of lipid nanoparticle manufacturing, starting from early stage formulation design, process development, scale-up and clinical manufacturing. Natalia holds an undergraduate degree in Chemistry from the University of British Columbia.

April 13, 2021
Tue 10:00 AM EDT

Duration 1H 0M

This live web event has ended.